30-day average of 10 articles ยท scale โ100 to +100
Across 10 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of Synopsys news is Somewhat Bullish (+45)
on a scale from โ100 to +100.
๐ Synopsys Q3 revenue hit $2.48B, up 42% year-over-year.
โ ๏ธ Export controls remain a top risk cutting off key markets.
Bullish +65
If You Invest $1,000 in Synopsys Today, Hereโs What It Could Be Worth by 2029
AI-generated analysis
Key insights
๐ Synopsys reported third-quarter revenue of $2.48 billion, a 42% year-over-year increase that significantly beat analyst estimates.
๐ฐ The company achieved non-GAAP EPS of $3.91, exceeding expectations and marking the fourth consecutive quarter of beating earnings targets.
๐ Management raised full-year guidance for revenue to between $9.690 billion and $9.740 billion following strong quarterly results.
๐ค CEO Sassine Ghazi highlighted accelerating design starts in AI, with over 30 active customer projects on the agentic AI platform.
๐ The new Multiphysics Fusion platform combining Synopsys and Ansys technology is expected to begin contributing to EDA growth in 2027.
๐ธ Management targets $400 million in synergies by year four from the Ansys acquisition, supported by a robust backlog of $10.9 billion.
โ ๏ธ Export controls and potential new Entity List restrictions are identified as top risks that could cut off key markets.
๐ The stock recently dropped 9.22% in delayed trading, trading at approximately $444.99 after a volatile month.
๐ฆ Synopsys carries about $10 billion in debt following the Ansys deal, impacting GAAP profits through amortization charges.
๐ Analyst consensus target price is set at $586.95 with 23 Buy ratings and zero Sells from Wall Street analysts.
๐ฎ Price prediction models suggest a $1,000 investment could grow to roughly $1,795 by 2029 in the base case scenario.
โ๏ธ The company relies on a small number of large customers, creating concentration risk if major chipmakers reduce spending.
๐ Bullish signals
๐Synopsys third-quarter revenue surged 42% to $2.48 billion, significantly beating the $2.44 billion estimate.
๐ฐThe company delivered non-GAAP EPS of $3.91, surpassing the $3.67 expectation for the fourth consecutive quarter.
๐Management raised full-year revenue guidance to a range of $9.690-$9.740 billion following strong quarterly performance.
๐คCEO Sassine Ghazi reported more than 30 active customer projects on the agentic AI platform, indicating growing software consumption.
๐The new Multiphysics Fusion platform combining Synopsys and Ansys technology is expected to drive EDA growth starting in 2027.
๐Analyst consensus target price stands at $586.95 with a high confidence level of 0.9 based on forward valuation metrics.
๐ธThe company maintains a strong backlog of $10.9 billion to support future revenue visibility post-acquisition.
๐ Risk factors
โ ๏ธExport controls and potential new Entity List restrictions are cited as top risks that could severely impact key markets.
โ๏ธThe company relies on a relatively small number of large customers, meaning a decline by a few chipmakers would hit results hard.
๐ฆSynopsys carries approximately $10 billion in debt after the Ansys deal, which impacts financial flexibility.
๐ฆQuarterly intangible assets amortization of roughly $404 million weighs on GAAP profits and reduces reported earnings.
๐The stock is volatile, having dropped 11.91% over the past month with a beta of 1.184 indicating higher sensitivity to market moves.
๐Any slowdown in AI spending could push results toward the downside scenario, potentially reducing the projected 2029 returns.
Article
Synopsys (SNPS) reported a significant beat in its third-quarter fiscal 2026 results, with revenue jumping 42% year-over-year to $2.48 billion against estimates of $2.44 billion. The company also delivered non-GAAP EPS of $3.91, surpassing the expected $3.67, marking the fourth consecutive quarter of beating earnings per share expectations. Following this strong performance, management raised its full-year guidance for revenue to a range between $9.690 billion and $9.740 billion, and increased non-GAAP EPS guidance to between $15.04 and $15.10.
The article outlines a price prediction model projecting that a $1,000 investment in Synopsys could be worth approximately $1,795 by 2029 in the base case scenario, representing a total return of roughly 79.49%. This projection is based on a current share price near $445 and assumes continued growth driven by the increasing complexity of AI chip design and the company's expanding software consumption rates. Wall Street analysts generally align with this bullish outlook, maintaining a consensus target price of $586.95 with a high confidence level derived from forward valuation metrics.
Key drivers for future growth include the acceleration in design starts for AI chips and the integration of Synopsys technology with Ansys through their new Multiphysics Fusion platform, which is expected to contribute to EDA growth starting in 2027. However, significant risks remain, particularly regarding export controls and potential Entity List restrictions that could impact key markets. The company also faces challenges related to its balance sheet, carrying approximately $10 billion in debt post-acquisition and quarterly intangible asset amortization of roughly $404 million.
Investors should monitor the stock for volatility, as it has experienced a recent decline and trades with a beta of 1.184. The company's business model relies on selling design software rather than manufacturing chips, making it sensitive to broader slowdowns in AI spending. While the backlog stands at $10.9 billion, the concentration risk among a relatively small number of large customers remains a critical factor that could disproportionately affect results if major clients were to decline.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
Synopsys (SNPS) reported a significant beat in its third-quarter fiscal 2026 results, with revenue jumping 42% year-over-year to $2.48 billion against estimates of $2.44 billion. The company also delivered non-GAAP EPS of $3.91, surpassing the expected $3.67, marking the fourth consecutive quarter of beating earnings per share expectations. Following this strong performance, management raised its full-year guidance for revenue to a range between $9.690 billion and $9.740 billion, and increased non-GAAP EPS guidance to between $15.04 and $15.10.
The article outlines a price prediction model projecting that a $1,000 investment in Synopsys could be worth approximately $1,795 by 2029 in the base case scenario, representing a total return of roughly 79.49%. This projection is based on a current share price near $445 and assumes continued growth driven by the increasing complexity of AI chip design and the company's expanding software consumption rates. Wall Street analysts generally align with this bullish outlook, maintaining a consensus target price of $586.95 with a high confidence level derived from forward valuation metrics.
Key drivers for future growth include the acceleration in design starts for AI chips and the integration of Synopsys technology with Ansys through their new Multiphysics Fusion platform, which is expected to contribute to EDA growth starting in 2027. However, significant risks remain, particularly regarding export controls and potential Entity List restrictions that could impact key markets. The company also faces challenges related to its balance sheet, carrying approximately $10 billion in debt post-acquisition and quarterly intangible asset amortization of roughly $404 million.
Investors should monitor the stock for volatility, as it has experienced a recent decline and trades with a beta of 1.184. The company's business model relies on selling design software rather than manufacturing chips, making it sensitive to broader slowdowns in AI spending. While the backlog stands at $10.9 billion, the concentration risk among a relatively small number of large customers remains a critical factor that could disproportionately affect results if major clients were to decline.
๐ Synopsys Q3 revenue hit $2.48B, up 42% year-over-year.
๐ฐ Non-GAAP EPS reached $3.91 for the fourth straight quarter.
๐ Full-year revenue guidance raised to $9.69B-$9.74B range.
โ ๏ธ Export controls remain a top risk cutting off key markets.
๐ Stock dropped 9.22% in delayed trading at ~$445.
๐ Synopsys reported third-quarter revenue of $2.48 billion, a 42% year-over-year increase that significantly beat analyst estimates.
๐ฐ The company achieved non-GAAP EPS of $3.91, exceeding expectations and marking the fourth consecutive quarter of beating earnings targets.
๐ Management raised full-year guidance for revenue to between $9.690 billion and $9.740 billion following strong quarterly results.
๐ค CEO Sassine Ghazi highlighted accelerating design starts in AI, with over 30 active customer projects on the agentic AI platform.
๐ The new Multiphysics Fusion platform combining Synopsys and Ansys technology is expected to begin contributing to EDA growth in 2027.
๐ธ Management targets $400 million in synergies by year four from the Ansys acquisition, supported by a robust backlog of $10.9 billion.
โ ๏ธ Export controls and potential new Entity List restrictions are identified as top risks that could cut off key markets.
๐ The stock recently dropped 9.22% in delayed trading, trading at approximately $444.99 after a volatile month.
๐ฆ Synopsys carries about $10 billion in debt following the Ansys deal, impacting GAAP profits through amortization charges.
๐ Analyst consensus target price is set at $586.95 with 23 Buy ratings and zero Sells from Wall Street analysts.
๐ฎ Price prediction models suggest a $1,000 investment could grow to roughly $1,795 by 2029 in the base case scenario.
โ๏ธ The company relies on a small number of large customers, creating concentration risk if major chipmakers reduce spending.
Synopsys (SNPS) shares have declined 8.4% over the past month, underperforming the S&P 500 and sitting 12.6% below their yearly high. The article analyzes the company's historical resilience during market shocks, noting that while it has recovered from previous downturns with a median wait of 1.9 months, the recovery following the 2008-2009 crisis took significantly longer at 24.3 months.
Financially, Synopsys reported revenue of $2.48 billion in fiscal Q3 2026, representing a 42.4% year-over-year increase. Approximately $711 million of this revenue originated from its Ansys acquisition, marking one full year since the combination. However, operating margins have compressed to 11.0% over the trailing twelve months compared to 24.6% two years prior, though they improved to 14.5% in the latest quarter.
The company's balance sheet has shifted significantly with debt climbing to $10.8 billion at the end of July 2026, up from $0.67 billion two years ago, although it remains lower than the $15.1 billion recorded a year earlier. Management indicated that new chip designs from non-AI customers are slowing down, though design starts for AI customers continue to accelerate. The company raised its expected restructuring charges for fiscal 2026 and anticipates total GAAP costs between $8.667 billion and $8.742 billion.
Synopsys ended fiscal Q3 2026 with a backlog of $10.9 billion, which is modestly down from the previous quarter due to the sale of its processor IP solutions business. Investors are advised to monitor this backlog figure closely ahead of the fiscal Q4 2026 results expected in December 2026.
๐ Shares slipped 8.4% over past month, trading 12.6% below year-high.
๐ฐ Revenue surged 42.4% YoY to $2.48B in fiscal Q3 2026.
โ ๏ธ Restructuring charges raised; GAAP costs expected between $8.67B-$8.74B.
๐ Operating margins compressed to 11.0% over trailing twelve months.
๐ธ Debt rose to $10.8B, representing 12.1% of market value.
๐ Synopsys shares slipped 8.4% over the past month, outpacing the 3.3% dip in the S&P 500 and trading 12.6% below their highest close of the year.
๐ฐ Revenue surged 42.4% year-over-year to $2.48 billion in fiscal Q3 2026, with approximately $711 million attributed to the Ansys acquisition.
๐ Operating margins compressed to 11.0% over the trailing twelve months, down from 24.6% two years ago, before improving to 14.5% in the latest quarter.
๐ธ Debt levels increased to $10.8 billion at the end of July 2026, representing 12.1% of the company's market value compared to 19.4% for the S&P 500.
๐ Management noted that new chip designs from customers outside the AI sector have been slowing, though design starts among AI customers are accelerating.
โ ๏ธ The company raised its expected restructuring charges for fiscal 2026 and anticipates total GAAP costs between $8.667 billion and $8.742 billion.
๐ฆ Backlog stood at $10.9 billion at the end of fiscal Q3 2026, down modestly from the previous quarter due to the sale of its processor IP solutions business.
๐ Fiscal Q4 2026 results are expected in December 2026, with investors advised to watch the backlog figure closely for upcoming guidance.
Bullish Signals
Revenue grew 42.4% YoY to $2.48B in Q3 2026.
AI design starts accelerated among customers.
Operating margins improved to 14.5% from 9.5%.
Risk Factors
Shares slipped 8.4% over past month, underperforming S&P 500.
Operating margins compressed to 11.0%, down from 24.6% two years ago.
Debt climbed to $10.8 billion, up from $0.67 billion two years earlier.
Non-AI chip designs slowing create headwinds in non-AI revenue streams.
Restructuring charges raised for fiscal 2026 as cost-saving initiatives accelerate.
Bullish Signals
Revenue grew 42.4% year-over-year to $2.48 billion in fiscal Q3 2026, driven by a strong contribution of approximately $711 million from the Ansys acquisition.
Design starts among AI customers kept speeding up, indicating continued growth in the high-priority artificial intelligence segment.
Operating margins improved to 14.5% in the latest quarter compared to 9.5% a year earlier, showing recent stabilization in profitability.
Risk Factors
Shares slipped 8.4% over the past month, underperforming the broader S&P 500 index which only dipped 3.3%.
Operating margins have compressed to 11.0% over the trailing twelve months, significantly lower than the 24.6% recorded two years ago.
Debt levels climbed to $10.8 billion at the end of July 2026, up from $0.67 billion two years earlier, increasing leverage relative to market value.
New chip designs from customers outside the AI sector have been slowing, creating potential headwinds in non-AI revenue streams.
The company raised its expected restructuring charges for fiscal 2026 as it accelerates cost-saving initiatives.
Backlog decreased modestly to $10.9 billion at the end of fiscal Q3 2026, partly due to the sale of its processor IP solutions business.
AI integrationNew AI featuresAI-generated analysis
Synopsys Inc. is preparing to host its Israel Technology Symposium on November 4 in Herzliya, focusing heavily on AI-powered engineering productivity and advanced chip design. The agenda features sessions on verification, hardware-assisted validation, implementation, signoff, and large-scale system-on-chip architectures, aiming to demonstrate how the company leverages artificial intelligence to enhance workflow efficiency.
The event will also highlight synergies between Synopsys and Ansys capabilities regarding physical implementation, power integrity, and multiphysics analysis. Discussions will cover agentic AI and intelligent automation within design and verification workflows, positioning these technologies as central to future engineering insights for customers and technology leaders attending the forum.
๐ Synopsys hosts Israel Technology Symposium on Nov 4 focusing on AI productivity.
Synopsys is leveraging AI-powered engineering productivity and advanced chip design capabilities as central themes for its upcoming Israel Technology Symposium.
The company plans to highlight combined strengths with Ansys in physical implementation, power integrity, and multiphysics analysis during the event.
Risk Factors
Synopsys stock declined 0.59% to trade at 418.00 euros on November 1, 2026, falling below the previous Friday's Xetra close.
The upcoming Israel Technology Symposium is primarily a technology forum rather than a scheduled financial report, meaning immediate detailed financial guidance may be limited.
Synopsys (SNPS) shares have rallied significantly, rising 13.96% over the past week and 26.09% over the last 90 days, driven by analyst upgrades including a Zacks Rank #1 and lifted earnings estimates. The stock currently trades at $490.19, which is below the fair value estimate of $583.99 set by Simply Wall St analysts, suggesting potential upside despite recent momentum.
The company's strategic outlook is bolstered by its acquisition and integration of Ansys, positioning Synopsys as a global leader in engineering solutions from silicon to systems. Recent data indicates that the acquired Ansys business generated approximately $711 million in Q3 FY26 revenue, with an expected total contribution of $2.98 billion for FY26, supporting top-line growth and cross-selling opportunities.
However, the stock faces valuation concerns as it trades at a P/E ratio of 87.3x, significantly higher than the wider US software sector average of 31.1x and peer group average of 32.9x. Analysts warn that the bullish narrative could be compromised if the Ansys integration incurs prolonged costs or if demand from China fails to support the anticipated AI ramp-up.
Investors are weighing these high valuation premiums against the potential for continued growth driven by the expanded engineering portfolio. The article concludes that while Synopsys appears undervalued relative to its specific fair value framework, the high price tag represents a risk premium that shareholders must evaluate carefully against sector benchmarks.
๐ Shares surged 13.96% weekly and 26.09% over 90 days on upgrades.
๐ฐ Stock trades at $490.19, below $583.99 fair value estimate.
๐ค Ansys acquisition expected to contribute $2.98 billion by FY26.
โ ๏ธ High P/E ratio of 87.3x exceeds sector and peer averages.
๐จ๐ณ Risks include China demand failure or high Ansys integration costs.
๐ Synopsys shares have surged 13.96% in the past week and 26.09% over 90 days following analyst upgrades and lifted earnings estimates.
๐ฐ The stock currently trades at $490.19, which is below the estimated fair value of $583.99 according to Simply Wall St analysis.
๐ค The acquisition of Ansys positions Synopsys as a global leader in engineering solutions with an expected FY26 contribution of approximately $2.98 billion.
โ ๏ธ Synopsys trades at a high P/E ratio of 87.3x, significantly above the wider US software sector average of 31.1x and peer average of 32.9x.
๐จ๐ณ The company faces specific risks if China-related demand fails to support its AI ramp-up or if Ansys integration costs exceed expectations.
Bullish Signals
Shares rallied 13.96% weekly and 26.09% over 90 days.
Analysts upgraded stock with Zacks Rank #1 and higher EPS estimates.
Ansys integration adds $2.98B to FY26 revenue.
Risk Factors
P/E ratio is 87.3x, far above sector and peer averages.
Ansys integration delays or weak China demand hurt AI ramp.
Bullish Signals
Synopsys shares have rallied 13.96% over the past week and 26.09% over 90 days, reflecting strong investor momentum and recent analyst upgrades.
Analysts have assigned the stock a Zacks Rank #1 and lifted earnings estimates, expecting higher EPS for the current quarter compared to the same period last year.
The integration of Ansys positions Synopsys as a global leader in engineering solutions, with the acquired business expected to contribute approximately $2.98 billion to FY26 revenue.
Risk Factors
The stock trades at a P/E ratio of 87.3x, which is substantially higher than the wider US software sector average of 31.1x and peer group average of 32.9x.
The bullish narrative faces risks if the Ansys integration drags on costs longer than expected or if China-related demand fails to support the AI ramp.
Shares of Synopsys (SNPS) rose 5.6% on Monday, October 26, 2026, significantly outpacing the broader S&P 500 and its sector peers. The stock's advance occurred without any specific company announcements or SEC filings from Synopsys itself, suggesting the move was driven by market dynamics rather than internal corporate news.
The rally appears linked to positive performance from peer competitor Cadence Design Systems, which beat earnings estimates and raised its full-year revenue outlook to 21% growth. Synopsys management previously highlighted strong design activity among AI and high-performance compute customers, noting that its Design IP segment grew during fiscal Q3 2026 due to broad demand for AI infrastructure.
Synopsys stock performance remains volatile relative to the broader market, having risen 5.6% on this day compared to a 1.8% gain for peer Cadence. The company trades at 9.2 times sales versus 3.2 for the S&P 500, and investors are awaiting its fiscal Q4 2026 revenue report in December, which is expected to fall between $2.53 billion and $2.58 billion.
๐ Synopsys shares surged 5.6% on October 26, 2026, outperforming S&P 500.
๐ป Peer Cadence beat estimates and raised guidance to 21% growth.
๐ Design activity is highest among AI and high-performance compute customers.
๐ Design IP segment grew in Q3 2026 due to AI demand.
๐ Stock volatility remains high with four large single-day rises recently.
๐ Synopsys shares surged 5.6% on October 26, 2026, significantly outperforming the S&P 500's 0.7% gain and its sector peers.
๐ป The stock rally coincided with peer Cadence Design Systems beating Q3 earnings estimates and raising its full-year revenue guidance to 21% growth.
๐ Synopsys management previously confirmed that design activity is highest among AI and high-performance compute customers building specialized chips.
๐ The company's Design IP segment experienced growth in fiscal Q3 2026 driven by broad demand for AI infrastructure solutions.
๐ Synopsys stock volatility remains high, having recorded four single-day rises of this magnitude or larger over the prior 365 days.
๐ฐ The company trades at a premium valuation of 9.2 times sales compared to the S&P 500's 3.2 times sales multiple.
๐ Investors are awaiting Synopsys' fiscal Q4 2026 revenue report scheduled for release in December 2026.
๐ฏ Management guidance for Q4 2026 revenue is set between $2.53 billion and $2.58 billion, serving as a key market watch item.
Bullish Signals
Shares rose 5.6% on October 26, 2026.
Design IP grew in Q3 2026 due to AI demand.
Design activity is highest among AI chip customers.
Bullish Signals
Shares of Synopsys rose 5.6% on October 26, 2026, significantly outpacing the S&P 500 and its sector peers.
The company's Design IP segment grew during fiscal Q3 2026 driven by broad AI infrastructure demand.
Management indicated that design activity is highest among AI and high-performance compute customers building increasingly specialized chips.
Morgan Stanley raised its price target for Synopsys Inc. to USD 574 on October 20, 2026, maintaining an Overweight rating following a robust fiscal third quarter. The company reported fiscal Q3 revenue of USD 2.48 billion, representing a significant 42.4 percent year-over-year increase, with diluted earnings per share reaching USD 2.84 and net income attributable to common shareholders totaling USD 545.8 million.
Synopsys also announced a new USD 1.0 billion share-repurchase program authorized on October 5, 2026, which covers up to 1.1 percent of its outstanding shares. This capital return initiative complements the strong operating growth, providing dual support for the company's valuation as analyst consensus targets remain elevated relative to current trading levels.
As of late October 2026, Synopsys held a market capitalization of USD 82.4 billion and traded within its established 52-week range. The stock price at EUR 383.75 on October 26 was slightly below the recent Xetra close, while the broader analyst consensus average target sits at USD 586.95, suggesting continued positive sentiment from Wall Street regarding the semiconductor design automation leader's performance.
๐ Morgan Stanley raised SNPS price target to USD 574 with Overweight rating.
๐ฐ Q3 revenue surged 42.4% YoY to USD 2.48 billion.
๐ EPS climbed to USD 2.84 with net income of USD 545.8 million.
๐ SNPS authorized new USD 1.0 billion share repurchase program.
๐ฏ Average analyst consensus target is USD 586.95, high targets reach USD 700.
๐ Morgan Stanley raised its Synopsys price target to USD 574 on October 20, 2026, maintaining an Overweight rating.
๐ Diluted earnings per share climbed to USD 2.84 with net income of USD 545.8 million for the quarter ended July 31, 2026.
๐ The company authorized a new USD 1.0 billion share-repurchase program covering up to 1.1 percent of outstanding shares.
๐ Synopsys stock traded at EUR 383.75 on October 26, 2026, slightly below the EUR 386.00 Xetra close.
๐ข The company maintains a market capitalization of USD 82.4 billion as of October 23, 2026.
๐ฏ The average analyst consensus target is USD 586.95, with high targets reaching USD 700.00.
๐ป Synopsys operates in the Technology / Software - Infrastructure sector and recently held its 2026 Investor Day.
Bullish Signals
Morgan Stanley raised price target to $574, Overweight rating.
Q3 revenue accelerated 42.4% YoY to $2.48 billion.
EPS rose to $2.84 with net income of $545.8M.
Authorized $1.0B share repurchase program for capital allocation.
Bullish Signals
Morgan Stanley raised its price target for Synopsys to USD 574, a 14.8 percent increase from the previous target of USD 500, maintaining an Overweight rating.
Fiscal third-quarter revenue accelerated significantly by 42.4 percent year-over-year to reach USD 2.48 billion, demonstrating strong top-line growth.
Diluted earnings per share increased to USD 2.84 with net income attributable to common shareholders reaching USD 545.8 million for the quarter ended July 31, 2026.
The company authorized a new USD 1.0 billion share-repurchase program covering up to 1.1 percent of outstanding shares, signaling confidence in its capital allocation strategy.
Analyst consensus targets remain elevated with an average of USD 586.95 and a high target of USD 700.00, indicating strong institutional support.
Synopsys Inc. provided updated fiscal 2027 revenue guidance ranging from USD 11.10 billion to USD 11.20 billion, with a midpoint of USD 11.15 billion representing approximately 15% growth. This outlook was presented during the company's Investor Day on September 30, 2026, establishing a clear benchmark for future performance expectations.
The company also outlined aggressive margin targets, aiming for a non-GAAP operating margin of 44% in fiscal 2027 and expanding that to 50% by fiscal 2030. Additionally, Synopsys plans to execute approximately USD 1.00 billion in share repurchases, subject to prevailing market conditions, signaling confidence in its capital allocation strategy.
Recent financial performance showed strong momentum with fiscal third-quarter revenue reaching USD 2.477 billion, a 42.40% year-over-year increase driven by the full quarter contribution from the Ansys acquisition. However, management noted that this growth rate is less comparable to prior periods due to the partial contribution of Ansys in the same quarter last year.
Despite the positive guidance and recent earnings beat, Synopsys stock fell 1.70% to EUR 405.00 on October 20, 2026. The company explicitly identified material uncertainties including export restrictions, concentration risk among a small number of large customers, and execution risks associated with integrating the Ansys acquisition.
๐ Synopsys guides fiscal 2027 revenue between $11.1B and $11.2B, implying ~15% growth.
๐ฏ Company targets non-GAAP operating margin of 44% in FY2027 and 50% by FY2030.
๐ฐ Plans approximately $1.0B in share repurchases subject to market conditions.
โ ๏ธ Management cites export restrictions and large customer dependence as material uncertainties.
๐ Stock fell 1.7% to โฌ405 despite positive guidance and recent earnings beat.
๐ Synopsys set fiscal 2027 revenue guidance at USD 11.10 billion to USD 11.20 billion, implying roughly 15% growth.
๐ฏ The company targets a non-GAAP operating margin of 44% for fiscal 2027 and 50% by fiscal 2030.
๐ฐ Synopsys plans approximately USD 1.00 billion in share repurchases subject to market conditions.
๐ Fiscal third-quarter revenue reached USD 2.477 billion, up 42.40% year over year including Ansys.
โ ๏ธ Management cites export restrictions and dependence on large customers as material uncertainties.
๐ The 42.40% Q3 growth includes a full quarter of Ansys versus a partial contribution a year prior.
๐ Stock fell 1.70% to EUR 405.00 despite the positive guidance and recent earnings beat.
๐๏ธ The next earnings release is expected on December 9, 2026, covering fiscal fourth-quarter results.
๐ค Synopsys recently added an Amazon IP agreement and an OpenAI partnership to its growth plan.
๐ผ Market capitalization stands at USD 87.1 billion with a 52-week range of USD 362.55 to USD 539.48.
Bullish Signals
Fiscal 2027 revenue guidance set at $11.1B-$11.2B, implying ~15% growth.
Risk Factors
Export restrictions pose material uncertainty for future operations.
Heavy reliance on few large customers is a risk.
Ansys acquisition execution risks are explicitly listed as material.
Q3 growth includes full Ansys quarter, making comparison less clean.
Bullish Signals
Synopsys set fiscal 2027 revenue guidance at USD 11.10 billion to USD 11.20 billion, implying approximately 15% growth.
The company targets a non-GAAP operating margin of 44% for fiscal 2027 and 50% by fiscal 2030.
AI integrationAcquisitionCompany updateAI-generated analysis
Synopsys (SNPS) is projected to deliver significant returns over the next five years, with analysts estimating a $10,000 investment could grow to approximately $20,481 by 2030 in a base case scenario. The company's growth thesis relies heavily on its dominant position in electronic design automation (EDA) software, which is essential for designing increasingly complex AI chips. Recent financial performance has been robust, with the company reporting 42.4% revenue growth and beating earnings estimates for four consecutive quarters.
The stock recently traded around $467, trading at a premium valuation of roughly 87x trailing earnings. Wall Street consensus targets suggest further upside potential, with a median analyst price target near $572. Management has raised full-year guidance, citing strong demand driven by the complexity of AI chip design and successful integration of Ansys simulation tools into their portfolio.
Key catalysts for future growth include the monetization of synergies from the Ansys acquisition, expected to start in fiscal 2027, and the adoption of new agentic AI design tools that could shift pricing models to increase earnings per customer. However, investors must weigh these opportunities against risks such as high debt levels from the Ansys deal, potential headwinds from U.S. export controls on China, and a volatile stock price with a beta of 1.208.
๐ Analysts project $10,000 investment reaching $20,481 by 2030 at 15.42% annualized return.
๐ Revenue surged 42.4% last quarter driven by AI chip design software demand.
๐ฐ EPS beat four quarters with non-GAAP EPS of $3.91 vs $3.67 consensus.
โ ๏ธ Ansys acquisition adds $10B debt and $2.98B revenue expected in fiscal 2026.
๐ Stock trades at 87x trailing earnings with high volatility despite strong buy ratings.
๐ Analysts project a $10,000 investment in Synopsys could reach approximately $20,481 by 2030 based on a base case annualized return of 15.42%.
๐ The company reported 42.4% revenue growth last quarter, driven by surging demand for EDA software required to design complex AI chips.
๐ฐ Synopsys has beaten EPS estimates for four consecutive quarters, with non-GAAP EPS of $3.91 exceeding the consensus of $3.67.
๐ Management raised full-year guidance for non-GAAP EPS to between $15.04 and $15.10, signaling confidence in double-digit growth for its core EDA business.
๐ค The Ansys acquisition is expected to contribute roughly $2.98 billion in revenue for fiscal 2026, with monetization of synergies beginning in fiscal 2027.
๐ง Twenty customers are currently evaluating Synopsys's new agentic AI design tools, which could transition from subscription licenses to consumption-based models.
๐ต The company achieved a strong non-GAAP operating margin of 41.6% last quarter, reflecting its high-margin software business model.
โ ๏ธ Synopsys carries approximately $10 billion in long-term debt resulting from the Ansys acquisition, which requires careful management.
๐ U.S. export control changes regarding China remain a top risk that could reduce sales if new limits are imposed.
๐ The stock trades at a high valuation of 87x trailing earnings and 23x forward earnings, leaving little room for error if AI demand cools.
๐ Shares recently fell 7.12% over the past week despite a strong 22.4% gain the previous month, highlighting the stock's high volatility with a beta of 1.208.
๐ Wall Street analysts maintain a positive outlook with 4 strong buy ratings and 19 buy ratings against only 2 hold ratings.
Bullish Signals
Revenue grew 42.4% to $2.48B driven by AI chip designs.
Risk Factors
$10B debt from Ansys creates financial leverage risks.
Bullish Signals
Synopsys reported 42.4% revenue growth last quarter, reaching $2.48 billion, driven by the increasing complexity of AI chip designs.
The company has beaten EPS estimates for four consecutive quarters, with non-GAAP EPS of $3.91 surpassing analyst consensus.
Management raised full-year guidance to non-GAAP EPS of $15.04-$15.10, projecting double-digit growth in its core EDA business.
The Ansys acquisition is expected to contribute approximately $2.98 billion in revenue for fiscal 2026, expanding the company's market reach.
Synopsys achieved a robust non-GAAP operating margin of 41.6% last quarter, demonstrating strong profitability in its software business.
Twenty customers are evaluating new agentic AI design tools that could shift pricing models to increase earnings per customer.
Wall Street analysts show strong confidence with a consensus price target of $572.17 and 23 buy/strong buy ratings versus no sell ratings.
Risk Factors
The stock carries approximately $10 billion in long-term debt from the Ansys acquisition, creating financial leverage risks.
U.S. export control changes on China remain a top risk that could significantly reduce sales if new restrictions are implemented.
Synopsys trades at a high valuation of 87x trailing earnings and 23x forward earnings, making it vulnerable to multiple compression.
The stock has a beta of 1.208, indicating it tends to swing more than the market overall, leading to recent volatility.
Risks include reliance on a few large customers that account for a significant share of total sales.
Tough competition in the EDA sector and the possibility that Ansys synergies fall short are cited as potential headwinds.
Synopsys Inc. (SNPS) closed its Xetra trading session on October 16, 2026, at a price of EUR 400.00. The company is preparing for the next trading session scheduled to begin on October 19, 2026.
Earlier in the month, on October 5, 2026, Synopsys announced an accelerated share repurchase agreement with JPMorgan Chase Bank, National Association. This financial move covers an aggregate repurchase amount of USD 1 billion, signaling a commitment to returning capital to shareholders.
๐ Synopsys stock closed at EUR 400.00 on Xetra on Oct 16, 2026.
๐ Trading resumes on Xetra starting Oct 19, 2026.
๐ฐ SNPS entered a USD 1B accelerated share repurchase with JPMorgan.
๐ Synopsys stock closed at EUR 400.00 on the Xetra exchange on October 16, 2026.
๐ The company is set to resume trading in the next Xetra session starting October 19, 2026.
๐ฐ Synopsys entered into a USD 1 billion accelerated share repurchase agreement with JPMorgan Chase Bank on October 5, 2026.
Bullish Signals
Initiated $1B accelerated share repurchase with JPMorgan Chase.
Closed Xetra session at EUR 400.00 on Oct 16, 2026.
Bullish Signals
Synopsys initiated a USD 1 billion accelerated share repurchase agreement with JPMorgan Chase Bank, demonstrating a strong commitment to returning capital to shareholders and potentially supporting the stock price.
The company successfully closed its Xetra trading session at EUR 400.00 on October 16, 2026, maintaining a stable market presence ahead of the next session.
Needham & Company raised its price target for Synopsys Inc. (SNPS) from USD 580.00 to USD 620.00 on October 12, 2026, while maintaining a Buy rating. The analyst upgrade cites strong third-quarter performance as the primary driver, noting that revenue growth provides a robust operating backdrop for the company's valuation.
Synopsys reported third-quarter revenue of USD 2.48 billion, representing a significant 42.40 percent increase year-over-year. Adjusted earnings per share reached USD 3.91, surpassing the consensus estimate of USD 3.67. This substantial growth in top-line revenue validates the bullish sentiment behind the analyst's higher price target.
As of October 16, 2026, Synopsys held a market capitalization of USD 87.6 billion with a price-to-earnings ratio of 79.91. While the stock traded at EUR 406.00 on European exchanges and USD 456.93 on Nasdaq, the fundamental financial metrics suggest continued strength in the electronic design automation sector.
๐ Needham raised Synopsys price target to USD 620.00 with Buy rating.
AI partnershipFinancial outlookNew AI featuresAI-generated analysis
Synopsys (SNPS) surged 8.8% to approximately $474.28 following a blockbuster Investor Day, positioning it as the top performer in the Nasdaq 100 for the session. The rally was driven by significant strategic partnerships with OpenAI and Amazon, alongside a raised full-year earnings outlook that exceeded analyst expectations.
Fundamentally, Synopsys reported fiscal Q3 revenue of $2.48 billion, representing a 42.4% year-over-year increase, while non-GAAP EPS reached $3.91 against estimates of $3.67. Management raised full-year EPS guidance to between $15.04 and $15.10, citing new AI revenue streams from customers testing agentic EDA tools under a 'subscription plus consumption' pricing model.
The company is executing its silicon-to-systems strategy with a long-term financial model targeting $400 million in revenue synergies from its Ansys integration by FY27. Analyst consensus targets the stock at $553.77, though 24/7 Wall St. sets a higher price target of $594.34 based on Synopsys trading at a cheaper 23x forward earnings multiple compared to rival Cadence's 32x.
Key risks include potential export controls related to China, total debt levels around $10 billion (with $3.45B paid down in Q1), and planned restructuring charges for Q4. The bull case relies heavily on the successful adoption of agentic AI tools and the realization of projected synergies from the Ansys merger.
๐ Stock surged 8.8% after strong Investor Day with OpenAI and Amazon partnerships.
๐ฐ Q3 revenue hit $2.48B, beating estimates by 42.4% year over year.
๐ Full-year EPS guidance raised to $15.04โ$15.10 driven by AI tools.
๐ค Targets $400M synergies from Ansys integration by fiscal year 2027.
โ ๏ธ Risks include China export controls, $10B debt, and Q4 restructuring charges.
๐ Synopsys stock surged 8.8% to $474.28 after a strong Investor Day featuring major partnerships with OpenAI and Amazon.
๐ฐ Fiscal Q3 revenue reached $2.48 billion, up 42.4% year over year, beating the $2.44 billion estimate.
๐ Management raised full-year EPS guidance to $15.04โ$15.10, driven by new AI revenue streams from agentic EDA tools.
๐ค The company targets $400 million in revenue synergies from its Ansys integration by fiscal year 2027.
๐ต Synopsys trades at a forward P/E of 23x, significantly cheaper than rival Cadence's 32x multiple despite faster growth.
๐ Analyst consensus price target is $553.77 with no 'Sell' ratings among the 23 analysts covering the stock.
โ ๏ธ Risks include export controls tied to China, total debt of approximately $10 billion, and Q4 restructuring charges.
Bullish Signals
Revenue hit $2.48B, up 42.4% YoY vs $2.44B estimate.
Risk Factors
Synergies from Ansys won't hit until FY27.
Bull case hinges on risky Ansys integration.
Bullish Signals
Synopsys reported fiscal Q3 revenue of $2.48B, a 42.4% year-over-year increase that significantly outpaced the $2.44B analyst estimate.
Non-GAAP EPS of $3.91 exceeded expectations of $3.67, demonstrating strong profitability despite integration costs.
Management raised full-year EPS guidance to a range of $15.04โ$15.10, signaling confidence in future growth trajectories.
Strategic partnerships with OpenAI and Amazon include multi-year IP agreements and custom silicon deals that anchor the bull case.
The company is pioneering 'subscription plus consumption' pricing for agentic EDA tools, with 20 customers currently testing these new AI revenue streams.
Synopsys trades at a forward P/E of 23x, offering a valuation discount to rival Cadence (CDNS) which trades at 32x despite slower growth.
The company successfully paid off $3.45B of debt in Q1 and expects free cash flow of approximately $2.6B for the current year.
Risk Factors
The bull case depends on the successful execution of the Ansys integration, with $400M in synergies not expected until FY27.
Wells Fargo analyst Joe Quatrochi upgraded Synopsys (SNPS) to an 'Overweight' rating and raised his price target to $475, citing accelerating demand in artificial intelligence and advanced semiconductor design automation. The analyst views the company as a primary beneficiary of growing AI adoption, which is driving strong customer commitments and positioning SNPS for expanding revenue momentum extending into fiscal year 2027.
Synopsys recently reported a robust quarter with a 42% year-on-year increase in revenue reaching $2.48 billion and earnings per share of $3.91, both figures exceeding market expectations. Despite the stock trading approximately 25% below its year-to-date high, the analyst highlights an attractive valuation at a price-to-sales ratio of about 10x, suggesting significant upside potential for investors.
The upcoming Analyst Day scheduled for September 30 is identified as a key near-term catalyst expected to reveal long-term growth initiatives and strategic progress in intellectual property solutions. While the stock faces a historical seasonal weakness in September with an average decline of 3.55%, the consensus market rating remains 'Strong Buy' with mean price targets indicating potential for a rally exceeding 35% through 2026.
๐ Wells Fargo upgraded SNPS to 'Overweight' with $475 price target.
๐ AI demand drives strong revenue momentum into fiscal year 2027.
๐ฐ Latest quarter saw 42% revenue growth to $2.48 billion.
๐ Stock trades 25% below year-to-date high after sharp downtrend.
โ ๏ธ Historical pattern shows ~3.55% average September stock decline.
๐ Wells Fargo analyst Joe Quatrochi upgraded Synopsys (SNPS) to 'Overweight' and raised the price target to $475, signaling nearly 20% upside from current levels.
๐ Accelerating demand in AI and advanced semiconductor design automation is driving strong customer commitments and revenue momentum into fiscal year 2027.
๐ฐ Synopsys reported a 42% year-on-year revenue increase to $2.48 billion and earnings per share of $3.91 in the latest quarter, beating expectations.
๐ The stock is currently trading about 25% below its year-to-date high following a sharp downtrend.
๐๏ธ An upcoming Analyst Day on September 30 is expected to serve as a catalyst for unlocking further shareholder value through long-term growth initiatives.
๐ The company trades at an attractive price-to-sales ratio of approximately 10x, which the analyst deems compelling for a fast-growing AI beneficiary.
๐ The consensus market rating stands at 'Strong Buy' with mean price targets suggesting potential for more than 35% rally through the remainder of 2026.
โ ๏ธ Synopsys has a history of losing about 3.55% on average in September due to seasonal trading patterns.
Bullish Signals
Wells Fargo upgraded to Overweight with $475 target, ~20% upside.
Risk Factors
Historical September losses average -3.55%, reducing near-term appeal.
Stock trades 25% below YTD high despite recent upgrade.
Bullish Signals
Wells Fargo upgraded Synopsys to 'Overweight' and raised the price target to $475, signaling nearly 20% upside from current levels.
Accelerating demand across AI and advanced semiconductor design automation is driving strong customer commitments and expanding revenue momentum into fiscal year 2027.
The company posted a 42% year-on-year increase in revenue to $2.48 billion and earnings per share of $3.91, both exceeding market expectations.
Synopsys is trading at an attractive price-to-sales ratio of about 10x, which the analyst finds compelling for a fast-growing AI beneficiary.
The upcoming Analyst Day on Sept. 30 is expected to outline long-term growth initiatives and strategic progress in IP solutions.
The consensus market rating sits at 'Strong Buy' with mean price targets indicating potential for more than 35% rally through the remainder of 2026.
Risk Factors
Synopsys has a history of losing about 3.55% on average in September, creating a seasonal pattern that makes it somewhat less attractive to own in the near term.
The stock is currently trading about 25% below its year-to-date high, reflecting a sharp downtrend prior to the analyst upgrade.
Synopsys (NASDAQ:SNPS) has faced headwinds in 2026, trading at $448.38 with a 10.76% decline over the past month and 4.54% year-to-date, despite its critical role as a duopoly leader in semiconductor design software. The company recently reported strong Q2 FY2026 results on May 27, 2026, with revenue of $2.276 billion growing 42% year-over-year and non-GAAP EPS of $3.35 beating consensus by 5.96%. Management subsequently raised full-year guidance to a midpoint of $9.665 billion in revenue and $14.76 in non-GAAP EPS.
Analyst sentiment remains mixed but constructive, with a consensus price target of $560.38 supported by major upgrades from Stifel and Citi following the earnings beat. The bull case relies on Synopsys's structural moat in electronic design automation (EDA), its new AI Product Suite, and expanding Design Automation margins projected at 43.3%. However, significant risks include a $10 billion long-term debt load, quarterly amortization of $403.6 million compressing GAAP profits, and shareholder lawsuits regarding Design IP disclosures.
24/7 Wall St. sets a year-end 2026 price target of $490.68, implying mid-single-digit upside from current levels with a 90% confidence rating. The thesis hinges on the company's ability to execute its silicon-to-systems platform and deliver credible long-term targets at the September 30 Investor Day. Key variables include the recovery of Design IP Solutions, potential synergies from the Ansys partnership, and the impact of AI capex normalization or further export control escalations under the Entity List.
๐ Stock down 10.76% monthly despite strong Q2 revenue growth.
๐ Revenue up 42% YoY with full-year guidance raised significantly.
Synopsys (NASDAQ:SNPS) stock is currently trading at $465, down 1% year-to-date, despite reporting a robust 42% year-over-year revenue growth to $2.28 billion in Q2 FY26 and non-GAAP EPS of $3.35 that beat estimates. The disconnect between strong fundamentals and stock performance is attributed to the balance sheet impact from the $35 billion Ansys acquisition, which added roughly $10 billion in long-term debt, alongside a planned divestiture of its Processor IP Solutions segment and a recent 'Sell' rating from Zacks citing premium valuation.
Analysts at the firm project a base case price target of $568.87, representing 22.38% upside, while Wall Street consensus sits at $560.38 with 68% bullish sentiment. The article argues that reaching a $600 price target by March 2027 is realistic but requires specific catalysts to align, including the realization of synergies from the Ansys deal in FY27 guidance, stabilization of the Design IP segment, and continued compounding of AI-driven EDA bookings.
Key bullish drivers include institutional validation from Norges Bank's new $730 million stake and Samsung Foundry's live AI design validation on 2nm nodes. Management has raised FY26 EPS guidance to a range of $14.72 to $14.80, though the primary risk remains potential delays in Ansys integration that could pressure margins into FY27 or an escalation of China Entity List restrictions affecting the company's exposure.
๐ Stock down 1% YTD despite 42% revenue growth to $2.28B.
๐ฆ $35B Ansys deal adds $10B debt and integration risks.
๐ Analyst target $560 with 21% upside potential.
๐ Bull case targets $600 by March 2027 via synergies.
โ ๏ธ Risks include delayed integration and China geopolitical exposure.
๐ Stock Performance: SNPS is down 1% YTD at $465 despite a 42% YoY revenue increase to $2.28 billion in Q2 FY26 and non-GAAP EPS of $3.35 beating the $3.16 estimate.
๐ฆ Acquisition Impact: The $35 billion Ansys deal has loaded the balance sheet with approximately $10 billion in long-term debt, creating integration risks that weigh on current sentiment.
๐ Segment Weakness: The Design IP segment is softening due to a planned divestiture of Processor IP Solutions, contributing to margin compression concerns flagged by Zacks.
๐ Analyst Targets: Wall Street consensus target is $560.38 with 21% upside, while the author's base case model projects $568.87 with a 90% confidence score.
๐ Bull Case Catalysts: Three specific catalysts support a move to $600 by March 2027: Ansys synergies appearing in FY27 guidance, Design IP stabilization, and no escalation of China Entity List restrictions.
๐ญ Samsung Validation: Samsung Foundry's AI design validation on 2nm nodes is live, serving as a key catalyst feeding the bull case for the stock.
๐๏ธ Institutional Support: Norges Bank has established a new $730 million stake in Synopsys, signaling strong institutional conviction in the company's long-term prospects.
๐ฐ Guidance Raise: Management raised FY26 EPS guidance to a range of $14.72 to $14.80, indicating confidence in near-term earnings performance.
โ ๏ธ Primary Risks: The main risks to the $600 target include delayed Ansys integration pressuring margins and potential geopolitical escalation regarding China exposure.
๐ Valuation Context: SNPS trades at roughly 31x forward earnings, sitting 14% below its 52-week high of $651.73 after an all-time high return of 781.07% over the last decade.
Bullish Signals
Revenue grew 42% YoY in Q2 FY26.
Non-GAAP EPS of $3.35 beat estimates.
FY26 EPS guidance raised to $14.72-$14.80.
Norges Bank added $730 million stake.
Stock trades at 31x forward earnings.
Risk Factors
$10B debt from $35B Ansys acquisition increases leverage risk.
Zacks 'Sell' rating cites premium valuation and margin compression.
Design IP softening due to Processor IP Solutions divestiture.
Delayed integration may pressure margins, derailing $600 target.
Bullish Signals
Strong revenue growth of 42% YoY in Q2 FY26 demonstrates robust demand for Synopsys' EDA tools amidst the AI chip boom.
Synopsys (NASDAQ:SNPS) is trading at $494.48, which is 24% below its 52-week high of $651.73, as Wall Street focuses on accounting noise from the $35 billion Ansys acquisition rather than the underlying agentic AI catalyst. The company sits at the center of advanced chip design, with its electronic design automation (EDA) software and the July 17, 2025 closing of the Ansys acquisition pushing it into full silicon-to-systems engineering. Following a 35.84% single-day drop on a Q3 FY2025 miss, the stock has stabilized as integration shifts from risk to reward.
The bull case is driven by strong demand, with Q2 FY2026 revenue reaching $2.275 billion, up 41.98% year over year, and non-GAAP EPS of $3.35 beating the consensus. Management raised full-year guidance to a $9.665 billion revenue midpoint and $14.76 non-GAAP EPS midpoint, targeting roughly $2.0 billion in free cash flow. Design Automation, comprising about 80% of revenue, expanded its adjusted operating margin to 43.3%, while the commercial ramp of Multiphysics Fusion software in late 2026 is expected to compress chip design timelines by up to 3x for major customers testing specialized AI agents.
However, bears argue that the Ansys deal saddled Synopsys with $10 billion in long-term debt and quarterly GAAP results are obscured by $403.6 million of intangibles amortization, causing Q2 GAAP net income to collapse 95.05% year over year. The Design IP segment is being restructured around a planned divestiture with restructuring charges hitting $234.2 million in H1 FY2026, and shareholder lawsuits remain unresolved, resulting in a trailing P/E of 114 on reported earnings. Shares are up only 5.27% year to date, well behind the S&P 500's roughly 10.8% YTD gain, with technical indicators signaling consolidation rather than a breakout.
The stock currently trades at $494.48 against a Wall Street consensus target of $560.38, implying roughly 13% upside, though analyst targets are based on guidance only. Of 25 analysts, 17 rate it Buy or Strong Buy, 7 Hold, and 1 Strong Sell, with institutional ownership at 90.89%. The forward P/E of 35 versus the trailing P/E of 114 reflects expected earnings normalization as Ansys amortization rolls through. Q3 FY2026 guidance calls for revenue of $2.41 to $2.46 billion and non-GAAP EPS of $3.63 to $3.69, which would extend the beat streak, while the September 30, 2026 Investor Day is expected to quantify Ansys synergy targets and frame the agentic AI roadmap. The risk/reward profile looks attractive up to $535, with downside cushioned by an $11.4 billion backlog, a $2 billion FCF run rate, and $3.46 billion in debt repayment during H1 FY2026.
๐ Q2 FY2026 revenue surged 42% YoY to $2.275 billion with EPS beating estimates.
๐ฐ Ansys acquisition expanded capabilities but added $10B debt and restructuring charges.
๐ฐ Non-GAAP EPS of $3.35 beat the $3.16 consensus by 5.96%.
๐ Management raised full-year guidance to a $9.665 billion revenue midpoint and $14.76 non-GAAP EPS midpoint.
๐ Design Automation, comprising ~80% of revenue, expanded its adjusted operating margin to 43.3%.
๐ค Multiphysics Fusion software is ramping up in late 2026 with AI agents compressing design timelines by 3x.
๐ธ The Ansys deal added $10 billion in long-term debt and $403.6 million in quarterly intangibles amortization.
๐ Q2 GAAP net income collapsed 95.05% year-over-year to $17.1 million due to restructuring charges.
โ๏ธ The Design IP segment is being restructured around a planned divestiture with unresolved shareholder lawsuits.
๐ Synopsys trades at a trailing P/E of 114 versus a forward P/E of 35 reflecting earnings normalization.
๐ Shares are up 5.27% year-to-date and 4.5% over one year, lagging the S&P 500's 10.8% gain.
๐ฏ The stock trades at $494.48 against a Wall Street consensus target of $560.38, implying ~13% upside.
๐ An Investor Day on September 30, 2026, is expected to reveal long-term targets and synergy details.
๐ก๏ธ Q3 FY2026 guidance calls for revenue between $2.41 billion and $2.46 billion with non-GAAP EPS of $3.63-$3.69.
๐ฐ The company holds a $11.4 billion backlog and generates roughly $2 billion in free cash flow annually.
๐ Institutional ownership stands at 90.89% with 17 out of 25 analysts rating the stock Buy or Strong Buy.
โ ๏ธ The thesis risks breaking if Design IP weakness widens or another significant earnings miss occurs.
Bullish Signals
Synopsys Q2 FY2026 revenue hit $2.275B, up 41.98% YoY.
Non-GAAP EPS of $3.35 beat estimates by 5.96%.
Full-year guidance raised to $9.665B revenue and $14.76 EPS.
Design Automation adjusted operating margin expanded to 43.3%.
$11.4B backlog and $2B free cash flow ensure stability.
17 of 25 analysts rate stock Buy or Strong Buy.
Stock trades at $494.48 with ~13% upside to $560.38 target.
Institutional ownership stands at 90.89%.
Risk Factors
Stock trades at $494.48, 24% below 52-week high.
Shares dropped 35.84% on Q3 miss before stabilizing.
$10B debt saddles company after Ansys acquisition.
GAAP income collapsed 95.05% due to amortization.
$234.2M restructuring charges hit Design IP segment.
Unresolved shareholder lawsuits over prior disclosures.
Trailing P/E of 114 remains expensive on earnings.
Shares up only 5.27% YTD vs S&P 500's 10.8%.
Technical indicators signal consolidation, not breakout.
Bullish Signals
Synopsys reported Q2 FY2026 revenue of $2.275 billion, representing a robust 41.98% year-over-year growth.
Non-GAAP EPS of $3.35 beat the consensus estimate of $3.16 by 5.96%, demonstrating strong operational performance.
Management raised full-year guidance to a revenue midpoint of $9.665 billion and non-GAAP EPS midpoint of $14.76, signaling confidence in future demand.
The Design Automation segment expanded its adjusted operating margin to 43.3% from 40.9%, highlighting improved profitability.
Synopsys has a substantial $11.4 billion backlog and generates approximately $2 billion in free cash flow run rate, providing financial stability.
Analyst sentiment remains positive with 17 out of 25 analysts rating the stock as Buy or Strong Buy.
The company trades at $494.48 against a Wall Street consensus target of $560.38, implying roughly 13% upside potential.
Institutional ownership stands at 90.89%, indicating strong confidence from major investors in the company's long-term prospects.
Risk Factors
The stock trades at $494.48, which is 24% below its 52-week high of $651.73.
Following a 35.84% single-day drop on a Q3 FY2025 miss, the stock has stabilized but remains significantly depressed relative to recent highs.
The Ansys acquisition saddled Synopsys with $10 billion in long-term debt.
Quarterly GAAP results are obscured by $403.6 million of intangibles amortization, causing Q2 GAAP net income to collapse 95.05% year over year.
The Design IP segment is being restructured around a planned divestiture with restructuring charges hitting $234.2 million in H1 FY2026.
Shareholder lawsuits over prior Design IP disclosures remain unresolved.
The trailing P/E of 114 on reported earnings is not cheap, reflecting the impact of amortization and restructuring charges.
Shares are up only 5.27% year to date, well behind the S&P 500's roughly 10.8% YTD gain.
Technical indicators signal consolidation rather than a breakout, with the stock trading above its 50-day moving average of $463.89 and 200-day moving average of $467.86.
NVIDIA has expanded its strategic partnership with Synopsys following a $2 billion investment disclosed earlier in the year, which was confirmed as one of NVIDIA's top holdings in Q4 2025 alongside Intel. This investment is intended to accelerate debt repayment related to Synopsys' acquisition of Ansys, which closed in July 2025 and combined electronic design automation with physics-based simulation. The partnership underscores the critical role Synopsys plays in NVIDIA's chip design process, as every Blackwell 300 die and networking ASIC shipped by NVIDIA runs through Synopsys tools before production.
Synopsys reported strong financial performance for Q2 FY2026, with revenue reaching $2.28 billion, a 42% year-over-year increase, and non-GAAP EPS of $3.35, which beat consensus estimates by 5.96%. The Design Automation segment, accounting for approximately 80% of revenue, achieved adjusted operating margins of 43.3%, up from 40.9% the previous year. Management raised its full-year FY2026 revenue guidance to a midpoint of $9.665 billion and non-GAAP EPS to between $14.72 and $14.80, with free cash flow targets around $2.0 billion. CEO Sassine Ghazi attributed this growth to AI scaling semiconductor demand, architectural diversity, and increasing chip complexity.
Activist investor Elliott Investment Management has also taken a significant stake in Synopsys, acquiring a multibillion-dollar position and securing a board seat for managing partner Jesse Cohn in May. Elliott is pushing for margins comparable to Cadence's, leveraging the post-Ansys cost structure to achieve these targets. Synopsys shares closed at $508.35 on June 2, 2026, reflecting a 9.05% gain over the past year and an 8.22% increase year-to-date, though this lags behind NVIDIA's 62.23% annual gain. Analyst consensus targets a share price of $560.38 with 17 Buy or Strong Buy ratings against one Strong Sell, while the forward earnings multiple sits near 33x.
Despite the positive outlook, risks remain, including roughly $10 billion in long-term debt from the Ansys financing, restructuring efforts around the Design IP segment for a planned Processor IP Solutions divestiture, and ongoing export controls that could impact operations. The strategic logic behind NVIDIA's investment is clear: AI is making chip design exponentially more complex, and Synopsys provides the essential tools to solve these challenges. For investors, Synopsys represents a high-quality compounder with AI exposure that does not require betting on the next GPU cycle, with the September 30, 2026 Investor Day serving as the next key catalyst to watch.
๐ค NVIDIA and Synopsys deepen ties via $2B investment and shared strategic roles.
๐ Q2 FY2026 revenue surged 42% to $2.28B with margins hitting 43.3%.
โ ๏ธ Key risks include $10B debt, export controls, and planned IP divestiture.
๐ค NVIDIA disclosed an expanded strategic partnership with Synopsys tied to a $2 billion investment earlier this year.
๐ Q4 2025 13F filings flagged Synopsys as one of NVIDIA's top holdings alongside Intel.
๐ฐ Synopsys confirmed a $2.0 billion private placement in Q1 FY2026 to accelerate debt repayment from the Ansys deal.
๐ This represents a rare strategic position where the buyer and customer are the same entity.
๐ญ NVIDIA is the world's most important chip designer while Synopsys provides the software tools used for that design.
๐ Q2 FY2026 revenue hit $2.28 billion, up 42% year over year with non-GAAP EPS of $3.35.
๐ฏ The Design Automation segment posted adjusted operating margins of 43.3%, up from 40.9% a year earlier.
๐ข Management raised FY2026 revenue guidance to a midpoint of $9.665 billion and non-GAAP EPS to $14.72-$14.80.
๐ CEO Sassine Ghazi attributed strength to AI scaling semiconductor demand and architectural complexity.
๐๏ธ Activist Elliott Investment Management acquired a multibillion-dollar stake and won a board seat for Jesse Cohn in May.
๐ Synopsys shares closed at $508.35 on June 2, 2026, up 9.05% over the past year.
๐ฏ Analyst consensus carries a target of $560.38 with 17 Buy or Strong Buy ratings against 1 Strong Sell.
โ ๏ธ Roughly $10 billion in long-term debt remains from the Ansys financing as a key risk factor.
๐ The Design IP segment is being restructured around a planned Processor IP Solutions divestiture.
๐ Export controls remain a significant swing factor for the company's operations.
๐ The September 30, 2026 Investor Day is identified as the next catalyst worth watching for investors.
Bullish Signals
Synopsys Q2 FY2026 revenue hit $2.28B, up 42% YoY.
Non-GAAP EPS of $3.35 beat consensus by 5.96%.
Design Automation margins expanded to 43.3% from 40.9%.
Full-year guidance raised to $9.665B revenue and $14.72-$14.80 EPS.
NVIDIA partnership and $2B investment highlight AI tool importance.
Elliott acquired stake, pushing for margin expansion vs Cadence.
Shares trade at 33x forward earnings despite 42% growth.
Analyst target price is $560.38 with 17 Buy ratings.
Risk Factors
$10B debt may pressure liquidity or raise interest costs.
Export controls could disrupt operations and revenue in key markets.
Bullish Signals
Synopsys reported Q2 FY2026 revenue of $2.28 billion, representing a strong 42% year-over-year growth driven by AI scaling semiconductor demand.
The company beat analyst consensus with non-GAAP EPS of $3.35, which was 5.96% higher than expected, demonstrating robust operational performance.
Design Automation segment margins expanded to 43.3%, up from 40.9% a year earlier, highlighting improved operating leverage and efficiency.
Management raised full-year FY2026 revenue guidance to a midpoint of $9.665 billion and non-GAAP EPS to $14.72-$14.80, signaling confidence in future growth.
NVIDIA's expanded strategic partnership and $2 billion investment underscores the critical importance of Synopsys tools in NVIDIA's AI infrastructure buildout.
Activist Elliott Investment Management acquired a multibillion-dollar stake and secured a board seat, pushing for margin expansion toward industry leader Cadence.
Synopsys shares are trading at a forward earnings multiple near 33x, which is considered full but not extreme for a software business growing at 42% annually.
Analyst consensus carries a target price of $560.38 with 17 Buy or Strong Buy ratings against only 1 Strong Sell, indicating strong market sentiment.
Risk Factors
Synopsys carries roughly $10 billion in long-term debt from the Ansys financing, which could pressure liquidity or increase interest expense risks.
Ongoing export controls remain a swing factor that could impact operations and revenue generation in key markets.
Synopsys, Inc. (SNPS) shares have risen 8.2% year-to-date, significantly outperforming the broader Zacks Computer - Software industry which declined 6.9%. Despite this price appreciation, the stock trades at a premium valuation with a P/E multiple of 44.45x compared to the industry average of 24.02x, resulting in a Zacks Value Score of F.
The company's Design IP segment faced notable pressure in the second quarter of fiscal 2026, with revenues dropping to $454.2 million from $482 million and adjusted operating margins falling to 24% from 31%. This weakness extended into the first half of the fiscal year, where margins averaged 21% versus 30% in the prior period.
Synopsys carries a substantial debt load of $10.014 billion as of April 30, 2026, against cash and short-term investments of only $2.484 billion, leading to higher financing costs. While consensus estimates for fiscal 2026 earnings show 12% year-over-year growth at $14.49, the stock faces stiff competition from rivals like Cadence, Keysight, and Siemens in the EDA space.
Due to margin compression, high debt, intense competition, and a premium valuation that leaves little room for execution errors, Zacks Investment Research assigns SNPS a Rank #4 (Sell). The firm advises investors to stay away from the stock at present despite its strong position in the AI-driven semiconductor cycle.
๐ Shares gained 8.2% YTD, outperforming industry decline.
๐ฐ Stock trades at 44.45x P/E with F Value Score.
Elliott Investment Management has reportedly established a multibillion-dollar stake in Synopsys (NasdaqGS:SNPS), marking the entry of a prominent activist investor into the company's ownership structure. This significant shareholder presence places Synopsys' capital allocation strategies, governance framework, and long-term priorities under intense scrutiny. Trading at $432.48, Synopsys has posted a 15.7% stock increase over the past three years and a 79.9% gain over five years, reflecting investor interest in its position as a central player in chip design and automation technologies. The arrival of Elliott introduces a new dynamic for current and prospective shareholders, focusing attention on how management might address potential changes to board composition, portfolio realignment, or the use of cash flow.
The implications of Elliott's involvement extend to several key strategic areas where activist investors typically engage. Given Synopsys' recent activities in integrating Ansys, rolling out AI-focused tools, and forming partnerships with NVIDIA, Elliott may push for transparency regarding milestones and returns from these major initiatives. Historical patterns suggest that activists like Elliott often demand clearer financial targets and more disciplined use of cash at large technology firms, which could lead to increased pressure on spending, headcount, or portfolio focus. Investors will likely watch closely how Synopsys balances potential buyback programs or debt reduction against the necessity of funding aggressive R&D in AI-centric electronic design automation (EDA), hardware-assisted verification, and digital twin offerings.
The presence of an active shareholder could both challenge and reinforce existing strategic narratives surrounding Synopsys' growth trajectory. On one hand, activist-driven demands for operational efficiency might disrupt complex programs such as the Ansys integration or large-scale AI chip verification platforms, potentially creating friction with rivals like Cadence and Siemens EDA in core markets. Conversely, a large engaged shareholder could bolster management's ability to pursue necessary portfolio realignments or tighten focus on higher-margin offerings by providing backing for decisions that some investors might question. Market observers should anticipate upcoming public letters, board discussions, or responses at events like CERAWeek and AI conferences as potential sources of clarity regarding the nature of this new partnership and any subsequent shifts in capital allocation policies.
โ ๏ธ Activist pressure may force trade-offs between capital returns and essential AI R&D funding.
๐ Engagement could drive portfolio realignment while disrupting complex Ansys integration efforts.
๐ Elliott Investment Management has reportedly accumulated a multibillion-dollar stake in Synopsys (NASDAQ: SNPS).
๐ฆ This position elevates Elliott to the status of a significant shareholder and introduces an activist investor into the company's governance.
๐ผ The move draws attention to potential shifts in Synopsys' capital allocation, board composition, and long-term strategic priorities.
๐ Synopsys shares are currently trading at $432.48, reflecting a 15.7% gain over the past three years and 79.9% over five years.
๐ค Elliott's presence highlights how activist investors might influence Synopsys while it invests heavily in AI-centric EDA and Ansys integration.
โ ๏ธ Increased pressure on spending, portfolio focus, or headcount could disrupt complex programs like the Ansys integration and digital twin rollout.
๐ฐ If Elliott advocates for aggressive capital returns, Synopsys may face a trade-off between buybacks and funding essential R&D against rivals.
๐ An engaged large shareholder could support management in pursuing portfolio realignment or tighter focus on higher-margin offerings.
โก Investors should watch for formal engagement announcements, public letters, or board discussions between Elliott and Synopsys management.
๐ Key areas to monitor include updated buyback plans, balance sheet targets, and changes in spending on AI-powered EDA tools.
๐งญ Analysts are assessing how activist influence might impact Synopsys' long-term positioning versus competitors like Cadence and Siemens EDA.
โ๏ธ The current investment narrative may need to incorporate the potential for activist-influenced changes to balance sheet structure or divestitures.
๐ Community discussions on Simply Wall St suggest focusing on transparency around milestones and returns from AI and Ansys initiatives.
๐ This article is general information and does not constitute financial advice or a recommendation to buy or sell any stock.
๐ง Readers can provide feedback or concerns regarding the content by contacting the editorial team at [email protected].
Bullish Signals
Synopsys stock has demonstrated strong long-term growth, rising 15.7% over the past 3 years and 79.9% over 5 years, highlighting investor confidence in the company's trajectory.
Elliott Investment Management is a respected activist investor with a history of pushing for clearer financial targets and more disciplined use of cash, which could enhance Synopsys' capital allocation efficiency.
A large, engaged shareholder like Elliott can support management when pursuing strategic changes such as portfolio realignment or tighter focus on higher margin offerings, providing backing for decisions that might otherwise face skepticism.
Elliott's involvement increases scrutiny on governance and capital allocation, potentially encouraging clearer financial targets, timelines, and communication around key initiatives like AI and Ansys integration.
Synopsys is already well-positioned with ongoing integrations such as Ansys, rollout of AI-focused tools, and partnerships with major players like NVIDIA, which provides a strong foundation for potential activist-driven optimization.
The company's focus on investing heavily in AI-centric EDA, hardware-assisted verification, and digital twin offerings aligns with high-growth industry trends, offering significant upside potential.
An activist presence could reinforce the narrative that Synopsys needs clear execution on its growth initiatives, adding external pressure to deliver transparency around milestones and returns from these strategic programs.
Risk Factors
Elliott's stake introduces active investor pressure that could disrupt complex programs such as the Ansys integration and rollout of AI-chip verification platforms.
Activist influence may force tighter scrutiny on R&D spending, potentially limiting aggressive investment in higher-value IP and AI tools where rivals like Cadence and Siemens are advancing.
The potential for more aggressive buybacks or portfolio realignment could strain cash flow needed to fund long-term innovation against competitors in the EDA market.
Any reduction in headcount or spending driven by activist demands could compromise Synopsys' competitive positioning versus peers such as Siemens and Cadence.
Management faces a trade-off between capital returns and maintaining sufficient liquidity for acquisitions, debt reduction, and funding digital twin offerings under potential activist oversight.
The stock's historical growth (15.7% over 3 years, 79.9% over 5 years) may face headwinds if operational priorities shift away from current AI-focused expansion plans.
Investor focus could now pivot toward governance changes and capital allocation shifts that may not align with management's existing strategic roadmap for Ansys integration.
Synopsys (SNPS) reported Q2 FY2026 revenue of $2.276 billion, representing a 42% year-over-year increase, with non-GAAP EPS of $3.35 beating analyst estimates of $3.1617. Despite the beat-and-raise, shares fell 7-8% as investors focused on a 6% decline in Design IP revenue, attributed to hyperscalers building proprietary chips rather than licensing Synopsys technology. GAAP net income dropped significantly to $17.1 million due to $403.6 million in intangibles amortization related to the Ansys acquisition, though the company remains strategically positioned with AI workloads driving demand for its EDA software portfolio and the Ansys integration now complete.
Analysts project a consensus price target of $544.99, while the article's author models a base case of $604.09 by May 2027, implying 25.68% upside with 90% confidence. Reaching a $700 price target by 2027 would require a 45.6% gain and significant multiple expansion to a forward P/E of 47x, contingent on Ansys synergies materializing, Design IP weakness stabilizing, and China revenue recovery in the second half of the year. Recent analyst upgrades from Citigroup to $610 and Rosenblatt to $575, combined with Elliott Management's board seat validating a margin improvement thesis, support the bullish outlook despite current valuation concerns at roughly 32x forward earnings.
๐ Revenue surged 42% to $2.276B, driven by AI complexity despite Design IP decline.
๐ฐ Non-GAAP EPS beat estimates at $3.35 as Ansys integration completes successfully.
๐ฏ Analysts target $604 by 2027 with high conviction in the base case model.
โ ๏ธ Growth hinges on stabilizing IP revenue and recovering China market share.
๐ Synopsys reported Q2 FY2026 revenue of $2.276 billion, representing a 42% year-over-year increase.
๐ฐ Non-GAAP earnings per share reached $3.35, surpassing the analyst estimate of $3.16.
๐ Shares fell 7-8% following the earnings report due to a 6% decline in Design IP revenue.
๐ค Hyperscalers are building proprietary chips, which is driving the decline in Synopsys' Design IP segment.
๐ง AI workloads are increasing semiconductor demand complexity, favoring Synopsys' EDA software portfolio.
๐ผ The $35 billion Ansys acquisition has been fully integrated into the company's operations.
๐ GAAP net income dropped to $17.1 million due to $403.6 million in Ansys intangibles amortization.
๐ Wall Street consensus price target is set at $544.99 with a majority of Buy and Strong Buy ratings.
๐ฏ The analyst's base case model predicts a stock price of $604.09 by May 2027, implying 25.68% upside.
๐ A bull case scenario projects the stock reaching $680.80, while a bear case sees it at $524.43.
๐ The analyst has high conviction (90%) in the base case despite the consensus being lower.
๐ฐ Reaching the $700 price target by 2027 would require an 11x additional multiple expansion.
๐ Three key conditions must be met: Ansys synergies materialize, Design IP stabilizes, and China revenue recovers.
๐ฃ๏ธ CEO Sassine Ghazi stated that AI is scaling semiconductor demand and driving complexity across the portfolio.
๐ฆ Citigroup raised its price target to $610, while Rosenblatt increased theirs to $575.
๐ Elliott Management's board seat validates the thesis for margin improvement within the company.
โ ๏ธ The primary risk remains a prolonged decline in Design IP revenue dragging down growth.
๐ Synopsys currently trades at roughly 32x forward earnings against forward EPS of $14.82.
๐ The stock has delivered a 10-year return of 828.77%, trading between its 52-week high and low.
๐ Achieving the $700 target demands structural changes including stabilization of IP revenue streams.
Bullish Signals
Synopsys Q2 FY2026 revenue hit $2.276B, up 42% YoY.
Non-GAAP EPS of $3.35 beat estimates at $3.16.
$35B Ansys acquisition fully integrated for market leadership.
20 analysts rate Synopsys Strong Buy or Buy.
Citigroup and Rosenblatt raised price targets to $610 and $575.
CEO says AI scaling semiconductor demand drives growth.
Risk Factors
Shares fell 7-8% despite beat-and-raise results.
Design IP revenue dropped 6% as hyperscalers build chips.
GAAP income collapsed to $17.1M due to amortization.
$700 target needs Design IP stabilization and China recovery.
Prolonged Design IP decline risks dragging growth down.
Bullish Signals
Synopsys reported Q2 FY2026 revenue of $2.276B, representing a strong 42% year-over-year growth.
Non-GAAP EPS of $3.35 beat analyst estimates of $3.1617, demonstrating solid earnings performance.
The $35 billion Ansys acquisition is now fully integrated, positioning Synopsys as the most strategically placed EDA franchise on the market.
Wall Street consensus shows 2 Strong Buy and 15 Buy ratings out of 20 total analyst recommendations.
Citigroup raised its price target to $610 and Rosenblatt to $575, indicating growing institutional confidence.
Elliott Management's board seat validates the margin improvement thesis, adding activist support to the company.
The stock has delivered a 10-year return of 828.77%, highlighting its long-term compounding potential.
CEO Sassine Ghazi stated that AI is scaling semiconductor demand and driving growth across the portfolio.
Risk Factors
Shares fell 7-8% immediately after reporting a beat-and-raise quarter, indicating investor skepticism despite strong revenue growth.
Design IP revenue declined 6% year-over-year as hyperscalers shifted to building proprietary chips instead of licensing Synopsys technology.
GAAP net income collapsed to $17.1 million due to $403.6 million in intangibles amortization related to the Ansys acquisition.
Reaching a $700 price target by 2027 requires Design IP weakness to stabilize and China revenue recovery, creating significant downside risk if these conditions fail.
The primary risk identified is a prolonged decline in Design IP revenue that could drag the overall growth narrative back down.
Synopsys (SNPS) reported strong Q2 earnings with revenue of $2.276 billion, beating guidance, and non-GAAP EPS of $3.35 exceeding expectations. Management raised full-year 2026 revenue guidance to $9.625-$9.705 billion and non-GAAP EPS to $14.72-$14.80, driven by AI demand in electronic design automation (EDA) and the ANSYS integration. The company highlighted significant cash generation with Q2 free cash flow of $575 million and a balance sheet showing $2.48 billion in cash and short-term investments against $10 billion in total debt.
Key growth drivers include over 30 full-flow technical wins for advanced nodes in EDA, early success from the multiphysics fusion platform which showed up to 3x faster design closure, and emerging interest in agentic AI-driven EDA with 20 customers evaluating solutions. Strategic product wins were noted in PCIe 7.0 IP with a win rate above 90% and successful tape-outs of advanced designs on 2nm processes. The ANSYS integration is progressing as planned, contributing $652 million in Q2 revenue, with management expecting to realize half of committed cost synergies by the end of fiscal 2026.
However, challenges remain including a year-over-year decline in Design IP revenue of about 6%, restructuring charges that weighed on GAAP profitability resulting in minimal GAAP EPS of $0.09, and ongoing leverage concerns with $10 billion in debt. The divestiture of the processor IP Solutions business will reduce fiscal 2026 revenue by approximately $40 million, and China remains a drag due to export restrictions. Management also noted accounting changes related to ANSYS channel revenue that add noise to top-line comparisons. Despite these risks, the company maintains confidence in its AI-driven growth trajectory and profitability scaling.
๐ Q2 revenue hit $2.276B, beating guidance with strong portfolio performance.
๐ฐ Non-GAAP EPS reached $3.35 while operating margin expanded to 39.5%.
๐ Fiscal 2026 revenue guidance raised to $9.625Bโ$9.705B including ANSYS.
๐ค AI demand drives growth in EDA, IP, and multiphysics simulation sectors.
โ ๏ธ GAAP EPS lagged at $0.09 due to restructuring charges and debt risks.
๐ Synopsys reported Q2 revenue of $2.276 billion, beating guidance with strong performance across its portfolio.
๐ฐ Non-GAAP EPS came in at $3.35, exceeding expectations while non-GAAP operating margin reached 39.5%.
๐ Management raised fiscal 2026 revenue guidance to a range of $9.625 billion to $9.705 billion, incorporating ANSYS contributions.
๐ต Free cash flow for Q2 was approximately $575 million, leaving the company with $2.48 billion in cash and short-term investments.
๐ The company launched a $250 million accelerated share repurchase program alongside roughly $50 million of open-market buybacks.
๐ค AI-driven demand is fueling growth in electronic design automation (EDA), IP, and multiphysics simulation sectors.
โก Synopsys logged over 30 full-flow technical wins for advanced nodes in Q2 with strong needs for hardware-assisted verification.
๐งฌ The multiphysics fusion platform showed early results with up to 3x faster design closure and higher ECO success rates in trials.
๐ค Agentic EDA is emerging as a long-term growth lever with 20 customers evaluating solutions across more than 25 specialized AI agents.
๐ PCIe 7.0 IP achieved a win rate above 90% with 18 new licenses in Q2, while UCIE lifetime wins surpassed 150.
๐ Design IP revenue declined about 6% year-over-year to $454 million, though it rose 12% sequentially from Q1 levels.
โ ๏ธ GAAP EPS was only $0.09 due to accelerated restructuring charges tied to the evolving portfolio, creating a wide gap with non-GAAP results.
๐ฆ Synopsys ended Q2 with approximately $10 billion of total debt, which management notes remains a central risk consideration.
๐ A shift in accounting for ANSYS channel revenue added $12.5 million to Q2 revenue but left earnings and cash unaffected.
๐จ๐ณ Design-start activity in China remains constrained by export restrictions and uncertainty, keeping expectations modest for that market.
โ๏ธ The divestiture of the processor IP Solutions business will trim fiscal 2026 revenue by around $40 million for the rest of the year.
๐ค ANSYS contributed roughly $652 million of revenue in Q2 with management expecting to realize half of committed cost synergies by end of fiscal 2026.
๐ฎ New technology monetization including multiphysics fusion and agentic EDA remains at an early stage with most engagements still in evaluation.
Bullish Signals
Synopsys Q2 revenue hit $2.276B, beating guidance.
Non-GAAP EPS of $3.35 exceeded expectations.
Fiscal 2026 revenue guidance raised to $9.625B-$9.705B.
Q2 free cash flow reached $575 million.
Company launched $250M accelerated share repurchase program.
Synopsys reported Q2 revenue of $2.276 billion, comfortably beating guidance with broad strength across its portfolio.
Non-GAAP EPS of $3.35 beat expectations, demonstrating disciplined cost control while investing in next-generation design tools.
Management raised fiscal 2026 revenue guidance to a range of $9.625 billion to $9.705 billion, embedding a larger contribution from ANSYS.
Non-GAAP EPS guidance was increased to $14.72 to $14.80, with the non-GAAP operating margin target improving to roughly 41% at the midpoint.
Free cash flow in Q2 reached about $575 million, leaving the company with $2.48 billion in cash and short-term investments.
Synopsys launched a $250 million accelerated share repurchase alongside roughly $50 million of open-market buybacks to return capital to shareholders.
In EDA, Synopsys logged more than 30 full-flow technical wins for advanced nodes in Q2, driven by AI demand from chipmakers.
The multiphysics fusion platform showed early results with up to 3x faster design closure and higher ECO success rates in customer trials.
Complex analog designs are seeing up to 2x faster turnaround times using the new multiphysics fusion technology.
PCIe 7.0 IP achieved a win rate above 90% with 18 new licenses in Q2, highlighting strong product-level successes.
UCIE lifetime wins surpassed 150, and the company delivered the industry's first HBM4 IP test chip while taping out a 64-gig design on a 2nm process.
ANSYS contributed roughly $652 million of revenue in Q2, with management expecting to realize about half of committed cost synergies by the end of fiscal 2026.
Agentic EDA is gaining traction with 20 customers evaluating solutions across more than 25 specialized AI agents for multi-year monetization.
Q3 revenue guidance stands at $2.41 billion to $2.46 billion, signaling continued growth momentum.
Management indicated that roughly half of the planned ANSYS cost synergies should be realized by year-end, supporting capital structure.
Risk Factors
Design IP revenue declined approximately 6% year-over-year, indicating softness in this segment despite sequential growth.
Restructuring charges increased GAAP costs and expenses by $2.156 billion, resulting in minimal GAAP EPS of only $0.09 compared to non-GAAP results.
The company carries approximately $10 billion in total debt, creating leverage concerns that could be exacerbated if macro conditions or demand soften.
The divestiture of the processor IP Solutions business will reduce fiscal 2026 revenue by approximately $40 million.
China remains a drag on growth due to export restrictions and broader uncertainty, limiting near-term revenue potential from the region.
Accounting changes related to ANSYS channel revenue add noise to top-line comparisons, complicating year-over-year performance analysis.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)